Significant lower levels of GAS5 were found in the plasma of HCC patients in comparison with control subjects and the ROC analysis evidenced the potential ability of circulating GAS5 levels to discriminate HCC patients from control subjects. Here, GAS5 is linked to hepatocellular carcinoma.